Autres langues Diagnamed Holdings Corp.

Actions

DMED

CA25245D1033

Marché Fermé - Canadian Securities Exchange Autres places de cotation 21:58:11 09/05/2024			Varia. 5j.	Varia. 1 janv.
0,035 ^CAD	0,00%		0,00%	+16,67%

25/04	La plateforme Brain Age® Brain Health AI de Diagnamed franchit une étape importante de validation clinique avec un article révisé par des pairs	CI
23/04	DiagnaMed Holdings Corp. annonce le lancement canadien de BRAIN AGE® Brain Health AI	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	25/04
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	25/04
Diagnamed?s Brain Age® Brain Health Ai Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	25/04
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI	23/04
DiagnaMed Holdings Corp. Announces Canadian Launch of BRAIN AGE® Brain Health AI	23/04
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI	03/04
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI	03/04
Diagnamed Holdings Corp. Adds New Launch Site of CERVAI Brain Health AI	03/04
DiagnaMed Announces BRAIN AGE Trademark Registration Approved by CIPO	20/03
DiagnaMed Holdings Corp. Announces Brain AGE Trademark Registration Approved by Canadian Intellectual Property Office	20/03
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO	20/03
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution	14/03
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution	14/03
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution	11/03
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution	11/03
DiagnaMed Holdings Corp. Accelerates Commercialization Initiatives of CERVAI Brain Health AI Solution	11/03
Diagnamed Holdings Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	01/03
DiagnaMed Announces Test Launch of CERVAI Brain Health in University Brain Health Center	28/02
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center	28/02
Diagnamed Holdings Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	30/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Diagnamed Holdings Corp.

Actions

DMED

CA25245D1033

Autres langues

Filtres